Links to 7 New HCV Articles

[Guest guest]

News

7new results for Hepatitis

Experts Propose Age-Based Hepatitis C Testing

WebMD

By Kathleen Doheny May 9, 2011 -- Screening all people born between 1946 and

1970 for the hepatitis C virus would greatly reduce the number of people with

advanced liver disease linked with the virus, according to new research. ...

See all stories on this topic »

Aethlon Medical Discloses FDA Meeting Request and Proposed Expansion of U.S. ...

PR Newswire (press release)

A significant proportion develops chronic hepatitis, cirrhosis, and even

hepatocellular carcinoma. Overall, chronic HCV patients on hemodialysis bear an

increased risk of liver-related morbidity and mortality, either during dialysis

or after renal ...

See all stories on this topic »

Buy Vertex Call Options as Drugmaker May Be Bought, Goldman Says

San Francisco Chronicle

May 9 (Bloomberg) -- Vertex Pharmaceuticals Inc. call options should be bought

because the maker of an experimental hepatitis C treatment may have " positive "

catalysts including a possible buyout bid, Goldman Sachs Group Inc. said. ...

See all stories on this topic »

Aethlon seeks FDA approval to test blood filter on hepatitis C

San Diego Union Tribune

Aethlon Medical will ask federal regulators to approve an initial clinical trial

of its blood filtering device on hepatitis C patients in the United States, the

San Diego company said Monday. The Hemopurifier was cleared for safety testing

in order to ...

See all stories on this topic »

FDA Recommends Second New Hepatitis C Drug for Approval

Citizens Report

In the last week, a Food and Drug Administration committee has unanimously

recommended two new hepatitis C drugs for approval. Telaprevir, a protease

inhibitor manufactured by Vertex Pharmaceuticals, prevents the hepatitis C virus

from replicating. ...

See all stories on this topic »

Viral Hepatitis: Cutting Edge Update. Action Needed to Reach Out to Silent ...

PR Web (press release)

Join the Hepatitis Foundation International as they discuss current issues in

viral hepatitis, including forthcoming therapies, shortcomings and improvements

to existing treatment and prevention initiatives, and the need to identify the

missing ...

See all stories on this topic »

Pharmaceuticals

Wall Street Journal

She concluded that the company's experimental drugs were poised to do what

current hepatitis C treatments couldn't: prevent the virus from developing

resistance to therapy. Ms. Bayko entered 2010 with a buy rating on Pharmasset

and kept it there all ...

See all stories on this topic »

Tip: Use a plus sign (+) to match a term in your query exactly as is. Learn

more.

..

[Guest guest]

News

7new results for Hepatitis

Experts Propose Age-Based Hepatitis C Testing

WebMD

By Kathleen Doheny May 9, 2011 -- Screening all people born between 1946 and

1970 for the hepatitis C virus would greatly reduce the number of people with

advanced liver disease linked with the virus, according to new research. ...

See all stories on this topic »

Aethlon Medical Discloses FDA Meeting Request and Proposed Expansion of U.S. ...

PR Newswire (press release)

A significant proportion develops chronic hepatitis, cirrhosis, and even

hepatocellular carcinoma. Overall, chronic HCV patients on hemodialysis bear an

increased risk of liver-related morbidity and mortality, either during dialysis

or after renal ...

See all stories on this topic »

Buy Vertex Call Options as Drugmaker May Be Bought, Goldman Says

San Francisco Chronicle

May 9 (Bloomberg) -- Vertex Pharmaceuticals Inc. call options should be bought

because the maker of an experimental hepatitis C treatment may have " positive "

catalysts including a possible buyout bid, Goldman Sachs Group Inc. said. ...

See all stories on this topic »

Aethlon seeks FDA approval to test blood filter on hepatitis C

San Diego Union Tribune

Aethlon Medical will ask federal regulators to approve an initial clinical trial

of its blood filtering device on hepatitis C patients in the United States, the

San Diego company said Monday. The Hemopurifier was cleared for safety testing

in order to ...

See all stories on this topic »

FDA Recommends Second New Hepatitis C Drug for Approval

Citizens Report

In the last week, a Food and Drug Administration committee has unanimously

recommended two new hepatitis C drugs for approval. Telaprevir, a protease

inhibitor manufactured by Vertex Pharmaceuticals, prevents the hepatitis C virus

from replicating. ...

See all stories on this topic »

Viral Hepatitis: Cutting Edge Update. Action Needed to Reach Out to Silent ...

PR Web (press release)

Join the Hepatitis Foundation International as they discuss current issues in

viral hepatitis, including forthcoming therapies, shortcomings and improvements

to existing treatment and prevention initiatives, and the need to identify the

missing ...

See all stories on this topic »

Pharmaceuticals

Wall Street Journal

She concluded that the company's experimental drugs were poised to do what

current hepatitis C treatments couldn't: prevent the virus from developing

resistance to therapy. Ms. Bayko entered 2010 with a buy rating on Pharmasset

and kept it there all ...

See all stories on this topic »

Tip: Use a plus sign (+) to match a term in your query exactly as is. Learn

more.

..